Yahoo Finance Plexus Corp. (NASDAQ:PLXS) Q2 2024 Earnings Call Transcript
Plexus Corp. (NASDAQ:PLXS) Q2 2024 Earnings Call Transcript April 27, 2024
Plexus Corp. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good morning, and welcome to the Plexus Corp. Conference Call regarding its Fiscal Second Quarter 2024 Earnings Announcement. My name is Britney Morgan, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. After a brief discussion by management, we will open the conference call for questions. The conference call is scheduled to last approximately one hour. Please note that, this conference call is being recorded. I would now like to turn the call over to Mr. Shawn Harrison, Plexus' Vice President of Investor Relations. Shawn?
Shawn Harrison: Thank you, Britney. Good morning everyone and thank you for joining us today. Some of the statements made and information provided during our call today will be forward-looking statements, including, without limitation, those regarding revenue, gross margin, selling and administrative expense, operating margin, other income and expense taxes, cash cycle, capital allocation, and future business outlook. Forward-looking statements are not guarantees, since there are inherent difficulties in predicting future results and actual results could differ materially from those expressed or implied in the forward-looking statements. For a list of factors that could cause actual results to differ materially from those discussed, please refer to the company's periodic SEC filings, particularly the risk factors in our Form 10-K filing for the fiscal year ended September 30, 2023, is supplemented by our Form 10-Q filings and the Safe Harbor and fair disclosure statement in our press release.
We encourage participants on the call this morning to access the live webcast and supporting materials at Plexus' website at www.plexus.com, clicking on investors at the top of that page. Joining me today are Todd Kelsey, Chief Executive Officer; Pat Jermain, Executive Vice President and Chief Financial Officer; and Oliver Mihm, Executive Vice President and Chief Operating Officer; Steve Frisch, our President and Chief Strategy Officer will unfortunately not be participating in today's call due to a death in the family. Our thoughts are with Steve and his family. With today's earnings call, Todd will provide summary comments referring before turning the call over to Oliver and Pat for further details. Let me now turn the call over to Todd Kelsey.
Todd.
Todd Kelsey: Thank you, Shawn. Good morning everyone. Please advance to Slide 3. I was pleased with the performance of our team during our fiscal second quarter, positioning Plexus to deliver ongoing industry-leading revenue growth along with sustained higher levels of profitability and increased free cash flow generation. Our go-to-market team delivered $255 million in new program wins, consistent with our fiscal first quarter, reflecting both market share gains and new outsourcing opportunities. Our ongoing wins momentum when combined with a $240 billion available market that is directly aligned to our strategy supports our expectations of delivering our 9% to 12% revenue CAGR goal. Our target remains a 5.5% GAAP operating margin exiting fiscal 2025, which equates to a greater than 6% non-GAAP operating margin, excluding stock-based compensation expense.
We continue to align our operations to achieve this return and expect sequential operating margin expansion in both our fiscal third and fourth quarters. We generated $65 million of free cash flow for the fiscal second quarter, a particularly strong result aided by continued progress on our working capital initiatives. I anticipate we will sustain our free cash flow momentum during our fiscal second half. Later in our prepared remarks, Pat will provide more details regarding our increased fiscal 2024 free cash flow forecast of approximately $100 million, as well as our plans for deploying excess cash to create additional shareholder value. Please advance to Slide 4 for a review of our fiscal second quarter results. We delivered fiscal second quarter results at the top end of our guidance with revenue of $967 million and non-GAAP EPS of $0.94, including $0.25 of stock based compensation expense.
Our non-GAAP operating margin of 4.2%, including approximately 70 basis points of stock-based compensation expense, met our expectation entering the quarter. Please advance to Slide 5. For the fiscal second quarter, we won 32 new manufacturing programs worth $255 million annually when fully ramped into production, supported by solid contributions from each of our market sectors, including our semi-cap subsector. In capitalizing upon the value created by our differentiated service offering and superior execution, as well as our focus on being the leader in highly complex products and demanding regulatory environments, our go-to-market organization is winning significant new outsourcing opportunities and gaining market share in support of sustaining Plexus' industry-leading revenue growth.
Please advance to Slide 6. We continue to integrate sustainable and responsible business practices into our operations and partner across our value chain to maximize our collective impact. A few highlights from the fiscal second quarter are as follows. We expanded our engagement with the UN Global Compact by joining the Climate Ambition Accelerator, a program that will help Plexus advance our energy transition strategy and accelerate progress towards setting science-based emissions reduction targets. We delivered on our fiscal 2024 initiative to assess our top 100 suppliers based on environmental and social impact criteria. These efforts build the foundation for a more transparent supply chain, aiding our goal to deliver a more sustainable, responsible and resilient sourcing strategy.
We strengthened the value-added capabilities we offered our customers to design, manufacture and service products, while reducing their environmental impact. We were recognized by Glasgow, Scotland Center for engineering, education and development as a finalist for their Net Zero Hero Award based on the capabilities we developed to assess the global warming potential of the products we help create. Pictures on the slide are members of our team in Scotland who delivered this work. We also partnered with Purdue University, on a custom curriculum to deepen our mutual understanding of eco-design principles in order to strengthen our sustainable product development solutions. Finally, we’re excited that later in the fiscal third quarter, we’ll release our annual sustainability report which captures the demonstrated progress made in fiscal 2023, to advance our sustainable and responsible business practices, as we realize our vision to help create the products that build a better world.
Please advance to Slide 7. We believe our revenue growth is in the early stages of inflecting higher, and for the fiscal third quarter, we’re guiding revenue of $960 million to $1 billion. Robust demand from our aerospace and defense market sector and ongoing gradual recovery in demand for semiconductor capital equipment that is aided by our market share gains over the past two years and continued new program ramps are more than mitigating the inventory correction headwinds from our Healthcare/Life Sciences and Industrial Market sectors. We are also forecasting non-GAAP operating margin of 5.2% to 5.6% which excludes approximately 70 basis points of restructuring charges associated with realigning our manufacturing capabilities to best support long-term customer needs and approximately 60 basis points of stock-based compensation expense.
Following these actions, we do not expect any further restructuring activity this fiscal year. As mentioned with our fiscal first quarter update, while we continue to measure our performance against GAAP metrics beginning with this fiscal third quarter, we’re excluding stock-based compensation expense from our operating margin and EPS guidance for easier comparability to peers. Therefore on a directly comparable basis, the midpoint of our fiscal third quarter non-GAAP operating margin guidance is 50 basis points higher than our fiscal second quarter results or at the high-end of our previously provided outlook of 30 basis points to 50 basis points of sequential operating margin expansion. Finally, we’re guiding fiscal third quarter non-GAAP EPS of $1.22 to $1.37, which excludes $0.21 of stock-based compensation expense and $0.21 of restructuring charges.
We continue to anticipate a strong finish fiscal 2024, positioning Plexus for further momentum into fiscal 2025. For the fiscal fourth quarter, we anticipate modest sequential revenue expansion, reflecting a continuation of the trends we expect for the fiscal third quarter. We’re also anticipating an additional 30 basis point to 50 basis point expansion in non-GAAP operating margin for the fiscal fourth quarter benefiting from volume leverage and operating improvements from our restructuring actions. At the mid-point, our non-GAAP operating margin exiting fiscal 2024 would be improved by 90 basis points when compared to our fiscal second quarter trough. In summary, I am pleased with how our team continues to execute for our shareholders, despite a challenging macro environment.
We remain focused on delivering our 9% to 12% organic revenue CAGR goal over the long-term, generating at least 5.5% GAAP operating margin in excess of 6% non-GAAP operating margin exiting fiscal 2025 and producing more consistent and greater free cash flow. I’ll now turn the call over to Oliver for additional analysis of the performance of our market sectors, Oliver.
Oliver Mihm: Thank you, Todd. And good morning. I will begin with a review of the fiscal second quarter performance of each of our market sectors. Our expectations for each sector for the fiscal third quarter and some directional sector commentary for fiscal 2024. I’ll also review the annualized revenue contribution of our wins performance for each market sector and region and then provide an overview of our funnel of qualified manufacturing opportunities. Starting with the Industrial sector on Slide 8. Revenue decreased 4% sequentially in the fiscal second quarter. This result met our expectation of a low single-digit decrease. Incremental revenue gains resulting from [resolve] (ph) supply chain constraints helped to compensate for softer end-market demand across certain market subsectors.
As we start the fiscal third quarter, inventory corrections are creating muted demand in multiple subsectors, offset in part by incremental increases in semi-cap and the early stages of recovery and broadband communications. This will result in flat revenue for the industrial sector for the fiscal third quarter. The industrial market sector had strong wins in the fiscal second quarter of $104 million. Wins were balanced across our subsectors and included three substantial program wins from existing customers in semi-cap. Additional new program wins for the fiscal second quarter included a win with a new customer that leverages AI-enabled technology to support more sustainable mining operations. Plexus was selected in part due to our capabilities across all of our services, including our ability to commercialize their design, assemble their product and provide sustaining services.
This program will be built and serviced in our Boise, Idaho facility. We also expanded our portfolio with a leading energy infrastructure customer to include engagement from a new division with a complex mechanical assembly that will be produced in our Xiamen, China campus. Looking ahead, we now anticipate a low single-digit decline in revenue for our industrial market sector for our fiscal 2024, as a gradual strengthening in semi-cap and the early stages of an anticipated communications uplift is more than offset by some delays in new program ramp timing and generally muted demand associated with customers working through inventory. Please advance to Slide 9. Revenue in our Healthcare/Life Sciences sector was down 1% sequentially for the fiscal second quarter, which modestly exceeded our expectation of a low single-digit decrease.
Demand increases inside the quarter from both existing programs and new product launches drove the improvement. In the near-term, we believe inventory corrections have largely subsided as revenue has stabilized. We expect our Healthcare/Life Sciences sector to be flat for the fiscal third quarter. Healthcare/Life Sciences sector wins for the fiscal second quarter were strong and totaled $109 million. Our wins included programs with two new customers. We have been awarded the production of a point-of-care diagnostic device for our Chicago, Illinois facility and an in vitro fertilization device for our Bangkok, Thailand facility. This marks our first healthcare life sciences win for our facility in Bangkok. Our fiscal second quarter wins also included a competitive market share gain with a long-standing customer awarding Plexus the production of a patient monitoring device due to our consistent exceptional operational performance and executive engagement and relationships.
The award is for our Guadalajara campus and marks the expansion of services for this customer to all three of our operating regions. Looking at the Healthcare/Life Sciences Market sector for fiscal 2024, as a result of inventory corrections and the approximately 5 percentage point growth headwind from the year-over-year reduction of components procured at above historical market prices, we continue to anticipate year-over-year revenue decline in the teens. The strength of new program wins gives us optimism for F ‘25 as they ramp to volume. Advancing to Slide 10. Our Aerospace and Defense sector increased 2% sequentially in the fiscal second quarter, meeting our expectation of a low single-digit decrease, improved supply chain performance and new program ramps proceeding ahead of schedule, contributed to the better than expected performance.
As we look to the fiscal third quarter, continued robust commercial aerospace demand and new program strength in the defense, security and space subsectors contribute to our expectation of a high single-digit increase for the aerospace and defense sector. Our fiscal second quarter wins for the aerospace and defense sector was strong at $42 million. We won two new programs with a recently acquired space subsector customers, supporting both military and commercial applications. These assemblies will be produced in our Kelso, Scotland facility. We also won the next generation product from an existing customer in our security subsector that will be built in our Penang, Malaysia campus. For fiscal 2024, aerospace and defense demand continues to be robust across all of our subsectors.
As a result, we continue to expect revenue growth for fiscal 2024 to exceed the high teens growth witnessed in fiscal 2023. Advancing to Slide 11, we can review the regional highlights of the manufacturing wins for the fiscal second quarter. The Americas wins were robust at $120 million and included a substantial win from an existing communications subsector customer for the production of its next-generation device in our Guadalajara, Mexico campus. The APAC region's fiscal second quarter wins of $94 million included a significant program expansion with an existing Healthcare/Life Sciences sector customer for a monitoring device. That device is built in our Penang, Malaysia campus. The EMEA region's second quarter wins of $41 million continues its recent strong wins performance and includes a substantial award from an existing semi-cap customer for our facility in Livingston, Scotland.
Please advance to Slide 12 for a review of our funnel of qualified manufacturing opportunities. Given the solid wins harvesting the past few quarters, as well as the typical ebb-and-flow of programs in-and-out of the funnel, the total funnel decreased to $3.5 billion. While sequentially lower, recall that our qualified funnel of manufacturing opportunities only breached the $3.5 billion threshold in fiscal 2023. Further, multiple market sectors noted the strength of their unqualified early-stage opportunities, as we continue to pursue programs in our large addressable market for outsourcing. The industrial sector funnel dipped slightly to $893 million. The funnel demonstrated resilience as we backfilled almost all of the wins. The semi-cap subsector had both strong wins and a substantial increase in the funnel size.
Aligned with our sector strategy, the opportunities reflected in our funnel are balanced across a variety of markets and across both existing customers, new divisions of existing customers and new customers. The Healthcare/Life Sciences sector wins performance contributed to the reduction in the funnel, declining to $1.8 billion. Strength in early stage opportunities provides optimism for future wins growth for the Healthcare/Life Sciences sector. The funnel for the Aerospace and Defense sector remains strong at $822 million with a great breadth and opportunities across the commercial aerospace, defense, security and space subsectors. Lastly, the funnel of opportunities for our engineering solutions remains robust. Customer decision-making saw incremental improvement during the fiscal second quarter, and our wins rebounded slightly as a result.
In addition, the market sector diversity within the funnel has improved, positioning Plexus to benefit from the future growth and significantly improved utilization of our engineering team. I’ll now turn the call over to Pat for an in-depth review of our financial performance. Pat?
Pat Jermain: Thank you, Oliver, and good morning, everyone. Our fiscal second quarter results are summarized on Slide 13. With revenue at the top-end of our guidance, gross margin of 9.1% came in above our midpoint due to slightly better fixed cost leverage. Productivity improvements and the start of savings from our restructuring efforts led to a sequential gross margin improvement despite the impact from seasonal compensation cost increases. Selling and administrative expense of $47.6 million was slightly above our guidance. However, as a percentage of revenue, SG&A of 4.9% was consistent with expectations. Non-GAAP operating margin of 4.2%, which excludes 120 basis points of restructuring charges, met the midpoint of our guidance.
This result included over 70 basis points of stock-based compensation expense. Recall last quarter that I mentioned we would begin sharing non-GAAP operating margin and EPS, exclusive of stock-based compensation expense for easier comparability to peers. This exclusion is reflected in our fiscal third quarter guidance. We’ve also included a table in our press release presenting operating margin and EPS, excluding restructuring charges and stock-based compensation expense for the last six quarters. Non-operating expenses of $10.5 million were favorable to expectations, due to lower-than-anticipated net interest expense. Non-GAAP diluted EPS of $0.94, which excludes $0.36 of restructuring charges, was at the top-end of our guidance due to the factors previously mentioned, along with favorable tax rate.
Turning to our cash flow and balance sheet on Slide 14. We were pleased with our free cash flow performance this quarter. We delivered $88 million in cash from operations and spent $23 million on capital expenditures, resulting in free cash flow of $65 million. This result significantly exceeded our net income and expectations. With the usage of cash in the fiscal first quarter, we have now generated free cash flow of $33 million through the first six months of fiscal 2024. During the quarter, we purchased approximately 186,000 shares of our stock for $17.6 million. We have approximately $38 million available under our current $50 million authorization and expect to consistently exercise the remaining amount during the second half of fiscal 2024, creating additional shareholder value.
We ended the fiscal second quarter with a cash balance of $265 million and total debt of $438 million. We had $261 million available to borrow under our credit facility and a conservative gross debt-to-EBITDA ratio of less than 1.8 times. In addition to funding our share repurchase authorization, we will use any excess cash to reduce borrowings under our credit facility. For the fiscal second quarter, we delivered return on invested capital of 9.9%, which was 170 basis points above our weighted average cost of capital. Cash cycle at the end of the fiscal second quarter was 91 days, 10 days favorable to expectations and sequentially improved by four days. Please turn to Slide 15 for details on our cash cycle. Our cash cycle improvement came from a combination of lower inventory days and higher days in advanced payments.
We were encouraged to see our supply chain and regional teams drive sequential improvement in both areas. They delivered a $56 million sequential reduction in gross inventory, which now sits at the lowest quarter end balance in two years. As Todd has already provided the revenue and EPS guidance for the fiscal third quarter, I'll review some additional details, which are summarized on Slide 16. Fiscal third quarter gross margin is expected to be in the range of 9.3% to 9.7%. At the midpoint, gross margin would be 40 basis points higher than the fiscal second quarter. Improved productivity across all of our regions better fixed cost leverage and savings recognized from our restructuring efforts are contributing to the anticipated improvement.
We expect selling and administrative expenses in the range of $45.5 million to $46.5 million, which is fairly consistent with the fiscal second quarter. Note that our SG&A guidance is inclusive of approximately $5.5 million of stock-based compensation expense. Non-operating expenses are anticipated to be in the range of $10.5 million to $11 million, which is also fairly consistent with the fiscal second quarter. Our non-GAAP effective tax rate for both the fiscal third quarter and fiscal year is expected to be in the range of 15% to 17%. With continued attention and focus on working capital efficiency, our expectation for the balance sheet is that we will recognize further reductions in working capital investments compared to the fiscal second quarter.
Based on our revenue forecast, we expect this level of working capital will result in cash cycle days in the range of 84 days to 88 days. At the midpoint, this would be a sequential improvement of five days, which is mainly related to reductions in gross inventory. This improvement should lead to another quarter of positive free cash flow. A couple of comments on the full year. We continue to expect capital spending in the range of $100 million to $120 million, which will equate to less than 3% of revenue. Last quarter, I mentioned that we could generate up to $50 million in free cash flow for the fiscal year with further progress on working capital initiatives, we’re now projecting approximately $100 million of free cash flow for fiscal 2024.
With that Britney let's now open the call for questions.
See also
Top 10 Artificial Intelligence (AI) SEO Tools in 2024 and
30 Small Business Ideas for Teens.
To continue reading the Q&A session, please click here.
